EASL would like to thank everyone who attended for making the Prague Special Conference on Therapy of Hepatitis C: Clinical Application and Drug Development, an enormous success.
This was a landmark event, being the first Special Conference on the topic of HCV co-organised by both EASL and the AASLD; the result was outstanding attendance, and a strengthened bond between the two associations.
EASL has prepared this Conference Highlights report featuring key topics discussed and presented during the Special Conference in Prague. This report will enable you to keep up to date with the latest happenings in the field.
A nuclear receptor links HIV drugs with liver disease
Physical activity linked to reduced risk of liver cancer
MICROB-PREDICT – €15 million EU funded microbiome research project kicks off